Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/1129
Title: Resting-state EEG alpha/theta power ratio discriminates early-onset Alzheimer's disease from healthy controls
Authors: Ozbek, Yagmur
Fide, Ezgi
Yener, Görsev
Keywords: Resting-state EEG
Early-onset AD
Late-onset AD
FFT
Alpha/theta ratio
Power
Mild Cognitive Impairment
Cerebrospinal-Fluid Biomarkers
Subjective Memory Complaints
Functional Connectivity
Quantitative Eeg
Hippocampal Atrophy
Alpha-Rhythms
Gray-Matter
Metabolic Function
Band Oscillations
Publisher: Elsevier Ireland Ltd
Abstract: Objectives: The present study aims to compare early-onset Alzheimer's disease (EOAD) patients with healthy controls (HC), and late-onset Alzheimer's disease (LOAD) patients using resting-state delta, theta, alpha, and beta oscillations and provide a cut-off score of alpha/theta ratio to discriminate individuals with EOAD and young HC. Methods: Forty-seven individuals with EOAD, 51 individuals with LOAD, and demographically-matched 49 young and 51 older controls were included in the study. Spectral-power analysis using Fast-Fourier Transformation (FFT) is performed on resting-state electroencephalography (EEG) data. Delta, theta, alpha, and beta oscillations compared between groups and Receiver Operating Characteristic (ROC) curve analysis was conducted. Results: Compared to healthy controls individuals with EOAD showed an increase in slow frequency bands and a decrease in fast frequency bands. Frontal alpha/theta power ratio is the best discriminating value between EOAD and young HC with the sensitivity and specificity greater than 80% with area under the curve (AUC) 0.881. Conclusions: EOAD display more widespread and severe electrophysiological abnormalities than LOAD and HC which may reflect more pronounced pathological burden and cholinergic deficits in EOAD. Additionally, the alpha/theta ratio can discriminate EOAD and young HC successfully. Significance: This study is the first to report that resting-state EEG power can be a promising marker for diagnostic accuracy between EOAD and healthy controls. (C) 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.
URI: https://doi.org/10.1016/j.clinph.2021.05.012
https://hdl.handle.net/20.500.14365/1129
ISSN: 1388-2457
1872-8952
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
143.pdf
  Restricted Access
1.24 MBAdobe PDFView/Open    Request a copy
Show full item record



CORE Recommender

WEB OF SCIENCETM
Citations

28
checked on Nov 20, 2024

Page view(s)

72
checked on Nov 18, 2024

Download(s)

2
checked on Nov 18, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.